M Guenoun, S Cohen, M Villaceque, A Sharareh, J C Dib, J Scwartz, O Hoffmann, L Ouazana, S Assouline, E Parrens, T Garban, V Pradeau, D Guedj-Meynier, B Lequeux, C Cohen, P Durand, F Dievart, T S Dhanjal, P Sabouret, N Lellouche
BACKGROUND AND AIMS: Since the introduction of direct oral anticoagulant (DOAC) for atrial fibrillation (AF) therapy, inappropriate and/or underdosing of these drugs has been a major clinical challenge. We evaluated the characteristics of AF patients treated with inappropriate and low dose DOACs. METHODS: AF patients treated with inappropriate and low dose DOACs from October 2021 to December 2021 were evaluated from the Prospective French National Registry (PAF)...
October 6, 2023: Europace: European Pacing, Arrhythmias, and Cardiac Electrophysiology